Benign multicystic peritoneal mesothelioma: use of hyperthermic intraperitoneal chemotherapy (HIPEC)

Sánchez Infantes S, Silvia Sánchez Infantes, César Lévano-Linares, Lévano-Linares C, Tamara Diaz Vico, Diaz Vico T, Pérez Domene MT, María Teresa Pérez Domene, Ana Torres Alemán, Torres Alemán A, Manso Abajo B, Belén Manso Abajo, Durán Poveda M, Manuel Durán Poveda
Revista espanola de enfermedades digestivas · 2025 · vol. 117(12) , pp. 799–800 · doi:10.17235/reed.2025.11416/2025 · PMID:40613524
case-report OA: closed public-domain-us ⤵ 1 in-corpus citation
Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper describes benign multicystic peritoneal mesothelioma, a rare neoplasm affecting women and presenting similarly to ovarian neoplasms, necessitating inclusion in differential diagnoses.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

This paper is a short letter describing Benign Multicystic Peritoneal Mesothelioma (BMPM), a rare mesothelial neoplasm estimated at 1–2 cases per million, first described in 1979, and noted to predominantly affect women of reproductive age. It highlights that BMPM is clinically and radiologically similar to ovarian neoplasms and that including gynecological pathology in the differential diagnosis is important; it also states BMPM has been associated with chronic inflammatory processes such as endometriosis or prior surgeries. The main caveat is that the piece provides no new patient data or detailed methodological results, functioning instead as a commentary on diagnosis and context. Relevance to endometriosis: the article specifically mentions endometriosis as one of the chronic inflammatory processes associated with BMPM, though the paper is primarily a diagnostic/clinical commentary rather than an endometriosis study.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Benign Multicystic Peritoneal Mesothelioma (BMPM) is a rare mesothelial neoplasm, first described in 1979, with an estimated incidence of 1-2 cases per million. It primarily affects women of reproductive age and has been associated with chronic inflammatory processes such as endometriosis or previous surgeries. Due to its clinical and radiological similarity to ovarian neoplasms, it is essential to include gynecological pathology in the differential diagnosis.
Full text 3,263 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Benign Multicystic Peritoneal Mesothelioma (BMPM) is a rare mesothelial neoplasm, first described in 1979, with an estimated incidence of 1–2 cases per million. It primarily affects women of reproductive age and has been associated with chronic inflammatory processes such as endometriosis or previous surgeries. Due to its clinical and radiological similarity to ovarian neoplasms, it is essential to include gynecological pathology in the differential diagnosis. New comment Comments No comments for this article

References

1. Mennemeyer R, Smith M. Multicystic, peritoneal mesothelioma: a report with electron microscopy of a case mimicking intra-abdominal cystic hygroma (lymphangioma). Cancer. 1979; 44(2):692-8. doi: 10.1002/1097-0142(197908)44:2692::aid-cncr2820440242>3.0.co;2-6. 2. Rapisarda A.M.C., Cianci A., Caruso S., et al. Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management. Arch. Gynecol. Obstet. 2018; 297 (6):1353-1375. DOI: 10.1007/s00404-018-4728-2. 3. Kepenekian V, Peron J, Goéré D, et al. Multicystic peritoneal mesotelioma treated wirh cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort. Int J Hyperthermia 2021; 38 (1): 805-814. 4. Shikanai S, Mariya T, Iwasaki M, et al. Benign Multicystic Peritoneal Mesothelioma Complicating Fertility Preservation. Gynecol Minim Invasive Ther. 2022; 11(2): 137-138. DOI: 10.4103/GMIT.GMIT_43_21. 5. Zahid A, Clarke L, Carr N, et al. Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hypethermic intraperitoneal chemotherapy. BJS open 2020 (0). DOI: 10.1093/bjopen/zraa001. Related articles Letter DOI: 10.17235/reed.2020.6755/2019 Letter to the Editor DOI: 10.17235/reed.2017.5179/2017 Citation tools Sánchez Infantes S, Lévano-Linares C, Diaz Vico T, Pérez Domene M, Torres Alemán A, Manso Abajo B, et all. Benign multicystic peritoneal mesothelioma: use of hyperthermic intraperitoneal chemotherapy (HIPEC). 11416/2025 Download the citation for this article by clicking on one of the following citation managers: Metrics Publication history Received: 15/06/2025 Accepted: 19/06/2025 Online First: 04/07/2025 Published: 12/12/2025 Article Online First time: 19 days Article editing time: 180 days Share This article hasn't been rated yet. Reader rating: Valora este artículo: Submit a manuscript Journal info Articles Submit a manuscript Journal info Articles Submit a manuscript The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva Cookie policy Privacy Policy Legal Notice © Copyright 2026 y Creative Commons. The Spanish Journal of Gastroenterology

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy Hyperthermic Intraperitoneal Chemotherapy

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-08-07T06:07:27.085738+00:00
pubmed
last seen: 2026-08-07T06:04:11.081019+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine